Everett Cunningham serves as the Executive Vice President and Chief Commercial Officer at Exact Sciences Corp, a leading provider of cancer screening and diagnostic tests. In this role, Cunningham is responsible for overseeing the company's commercial strategy, sales, marketing, and customer support operations. His leadership has been instrumental in driving the growth and adoption of Exact Sciences' flagship product, Cologuard, a non-invasive stool-based DNA test for colorectal cancer screening. Prior to joining Exact Sciences, Cunningham held several senior leadership positions in the healthcare and diagnostics industries. He spent over a decade at Roche Diagnostics, where he served as the Head of Molecular Diagnostics and led the company's efforts in developing and commercializing innovative diagnostic solutions. During his tenure at Roche, Cunningham played a key role in the successful launch of several groundbreaking products, including the cobas HPV test for cervical cancer screening. Before Roche, he held various sales and marketing positions at Abbott Laboratories and Bayer Diagnostics, where he honed his skills in driving commercial success and building strong customer relationships. Cunningham's extensive experience and strategic vision have been vital in positioning Exact Sciences as a leader in the cancer diagnostics market. Under his guidance, the company has expanded its commercial footprint, strengthened its sales force, and increased awareness of the importance of early cancer detection. Cunningham's commitment to improving patient outcomes and his ability to execute on the company's mission have made him an invaluable asset to Exact Sciences and the broader healthcare community.